Vardenafil "Stada" 5 mg filmovertrukne tabletter 丹麦 - 丹麦文 - Lægemiddelstyrelsen (Danish Medicines Agency)

vardenafil "stada" 5 mg filmovertrukne tabletter

stada arzneimittel ag - vardenafilhydrochloridtrihydrat - filmovertrukne tabletter - 5 mg

Cetraxal Comp 3+0,25 mg/ml øredråber, opløsning 丹麦 - 丹麦文 - Lægemiddelstyrelsen (Danish Medicines Agency)

cetraxal comp 3+0,25 mg/ml øredråber, opløsning

poa pharma scandinavia ab - ciprofloxacin, fluocinolonacetonid - øredråber, opløsning - 3+0,25 mg/ml

Cetraxal Comp 3+0,25 mg/ml øredråber, opløsning 丹麦 - 丹麦文 - Lægemiddelstyrelsen (Danish Medicines Agency)

cetraxal comp 3+0,25 mg/ml øredråber, opløsning

2care4 aps - ciprofloxacin, fluocinolonacetonid - øredråber, opløsning - 3+0,25 mg/ml

Carexarit 25 mikrogram overtrukne tabletter 丹麦 - 丹麦文 - Lægemiddelstyrelsen (Danish Medicines Agency)

carexarit 25 mikrogram overtrukne tabletter

2care4 generics aps - clonidinhydrochlorid - overtrukne tabletter - 25 mikrogram

Cetraxal Comp 3+0,25 mg/ml øredråber, opløsning 丹麦 - 丹麦文 - Lægemiddelstyrelsen (Danish Medicines Agency)

cetraxal comp 3+0,25 mg/ml øredråber, opløsning

orifarm a/s - ciprofloxacin, fluocinolonacetonid - øredråber, opløsning - 3+0,25 mg/ml

Entresto 欧盟 - 丹麦文 - EMA (European Medicines Agency)

entresto

novartis europharm limited - sacubitril, valsartan - hjertefejl - angiotensin ii antagonister, andre kombinationer, agenter handler på renin-angiotensin systemet - paediatric heart failureentresto is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction. adult heart failureentresto is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction.

Neparvis 欧盟 - 丹麦文 - EMA (European Medicines Agency)

neparvis

novartis europharm limited - sacubitril, valsartan - hjertefejl - agenter, der virker på renin-angiotensinsystemet - paediatric heart failureneparvis is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction (see section 5. adult heart failureneparvis is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction (see section 5.